TMBRQ — Trex Wind-Down Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$2.52m
- $0.08m
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Timber Pharmaceuticals Says Proposal To Approve Merger Agreement Was Not Approved In Special Meeting
Brief: Timber Pharmaceuticals Announces NYSE Acceptance Of Plan To Regain Listing Compliance
Timber shares nearly double on buyout deal with Leo Pharma
Brief: Timber Pharmaceuticals To Be Acquired By Leo Pharma
Brief: Timber Pharma Is Not In Compliance With NYSE American Continued Listing Standards
Brief: Timber Pharmaceuticals Announces FDA Grant Of Carc Waiver For Tmb-001
Brief: Timber Pharmaceuticals Provides Business Update And Announces First Quarter 2023 Financial Results
Brief: Timber Pharmaceuticals Announces Q4 Results
Timber Pharmaceuticals jumps on European 'orphan drug' tag for skin disorder therapy
Brief: Timber Pharmaceuticals Receives European Orphan Drug Designation For TMB-001
Brief: Timber Pharmaceuticals Regains Compliance With NYSE American Continued Listing Standards
Brief: Timber Pharmaceuticals Provides Business Update, Announces Q3 Financial Results
AMEX RESUMED TMBR PHRMCTL ORD
Brief: Timber Pharmaceuticals Announces Halt of Common Stock Trading
Brief: Timber Pharmaceuticals Receives European Orphan Designation For Autosomal Recessive Congenital Ichthyosis & Positive Comments On Pediatric Investigation Plan For Tmb-001 In Autosomal Recessive Ci & X-Linked Recessive Ichthyosis